H.R. 5548House115th Congress (2017-2019)In Committee

Water, Cosmetics, and Unwanted Pharmaceuticals Study Act

Introduced April 18, 2018

AI-Generated Summary

Updated April 15, 2026 at 9:19 PM UTC

The Water, Cosmetics, and Unwanted Pharmaceuticals Study Act directs the EPA to investigate the presence of prescription drugs and personal‑care items, such as cosmetics, in sources of drinking water. The study must identify what substances are found, how they get into water, their potential impacts on health and the environment, and ways to reduce or remove them. The EPA must work with the Health and Human Services Department, the US Geological Survey, other relevant agencies, industry, and consumer groups, and report its findings to Congress within four years. This affects the EPA, water utilities, pharmaceutical and personal‑care product manufacturers, and ultimately U.S. consumers of drinking water.

Key Provisions

  • EPA Administrator must conduct a study on pharmaceuticals and personal‑care products in drinking‑water sources, identifying detected substances and their concentration levels
  • The study must determine both point and non‑point sources of these substances in water supplies
  • It must assess the health, environmental, and safety impacts of the detected substances
  • The study must explore methods to control, limit, treat, or prevent their presence in drinking water
  • EPA must consult with HHS (FDA), USGS, other federal agencies, manufacturers, and consumer groups while conducting the study
  • EPA must submit a report of the study’s results to Congress no later than four years after enactment

Legislative Activity

Stay on top of the latest movement without scrolling through every action

1 earlier action
HouseIntro Referral Latest Action

Referred to the House Committee on Energy and Commerce.

April 18, 2018

View full timeline
HouseIntro Referral

Introduced in House

April 18, 2018

HouseIntro Referral

Referred to the House Committee on Energy and Commerce.

April 18, 2018

Floor Debate

2 members

What members said about H.R. 5548 on the floor

1 Republican1 Democrat
Tom McClintock
Rep. Tom McClintockR-CA-4 · Jul 23, 2018

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 5875) to amend the Pittman-Robertson Wildlife Restoration Act and the Dingell-Johnson Federal Aid in Sport Fish Restoration Act, to…

Madeleine Z. Bordallo
Rep. Madeleine Z. BordalloD-GU · Jul 23, 2018

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I am very pleased that the full House will soon vote on my bill, H.R. 5875, supported by all six Members of Congress representing…

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in HouseIssued April 18, 2018

I

115th CONGRESS

2d Session

H. R. 5548

IN THE HOUSE OF REPRESENTATIVES

April 18, 2018

Ms. Schakowsky introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To require the Administrator of the Environmental Protection Agency to conduct a study on the presence of pharmaceuticals and personal care products in sources of drinking water.

1.

Short title

This Act may be cited as the Water, Cosmetics, and Unwanted Pharmaceuticals Study Act.

2.

Presence of pharmaceuticals and personal care products in sources of drinking water

Subsection (a) of section 1442 of the Safe Drinking Water Act (42 U.S.C. 300j–1) is amended by adding at the end the following:

(11)

Presence of pharmaceuticals and personal care products in sources of drinking water

(A)

Study

The Administrator shall carry out a study on the presence of pharmaceuticals and personal care products in sources of drinking water, which shall—

(i)

identify pharmaceuticals and personal care products that have been detected in sources of drinking water and the levels at which such pharmaceuticals and personal care products have been detected;

(ii)

identify the sources of pharmaceuticals and personal care products in sources of drinking water, including point sources and nonpoint sources of pharmaceutical and personal care products;

(iii)

identify the effects of such pharmaceuticals and personal care products on humans, the environment, and the safety of drinking water; and

(iv)

identify methods to control, limit, treat, or prevent the presence of such pharmaceuticals and personal care products.

(B)

Consultation

The Administrator shall conduct the study described in subparagraph (A) in consultation with the Secretary of Health and Human Services (acting through the Commissioner of Food and Drugs), the Director of the United States Geological Survey, the heads of other appropriate Federal agencies (including the National Institute of Environmental Health Sciences), and other interested stakeholders (including manufacturers of pharmaceuticals and personal care products and consumer groups and advocates).

(C)

Report

Not later than 4 years after the date of the enactment of this paragraph, the Administrator shall submit to the Congress a report on the results of the study carried out under this paragraph.

(D)

Definitions

In this paragraph:

(i)

The term personal care product has the meaning given the term cosmetic in section 201 of the Federal Food, Drug, and Cosmetic Act.

(ii)

The term pharmaceutical has the meaning given the term drug in section 201 of the Federal Food, Drug, and Cosmetic Act.

.